Moderately to Severely Active Crohn Disease trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Moderately to Severely Active Crohn Disease trials nationally

Cities in Illinois

Recruiting trials in Illinois

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
  NCT06456593 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Evanston